The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer

intramuscular injection administered once/day for 2 consecutive days at Week 3; then once annually for subjects who meet criteria.

therapeutic dose administered orally to treat thyroid cancer at Week 8. 5-7 days later, the post-treatment I-131 Whole Body scan w/ SPECT is performed; then administered once annually, if the patient needs to be re-treated

one capsule ingested orally once at Week 3, and Week 8; then administered once annually to subjects who meet criteria.

withdrawal of thyroid hormone during weeks 4 through 8